JP Patent

JP5576018B2 — プロスタミド含有生分解性眼内インプラント

Assigned to Allergan Inc · Expires 2014-08-20 · 12y expired

What this patent protects

Patent listed against Lumigan.

Drugs covered by this patent

Lumigan (BIMATOPROST)

Patent Metadata

Patent number: JP5576018B2
Jurisdiction: JP
Classification: —
Expires: 2014-08-20
Drug substance claim: No
Drug product claim: No
Assignee: Allergan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.